| Molecular formula | C17H22N2O4 |
|---|
| Molecular weight | 318.4 g/mol |
|---|
| Registered trials | 0 |
|---|
| PubChem CID | 180496 |
|---|
Regulatory Status
Noopept is classified as an unapproved research compound. No regulatory agency has reviewed or approved a label for this substance, and it is not authorized for any medical use.
What Noopept Is
Noopept is a small molecule with the chemical formula C17H22N2O4 and a molecular weight of 318.4. Its PubChem entry (CID 180496) documents the compound's structure, but no approved drug label, mechanism of action, or indication exists in regulatory databases.
Clinical Trial Footprint
There are no registered clinical trials for noopept in the dataset reviewed. This means there is no available trial-phase information, no recruitment status, and no study population data to reference for this compound.
FAQ
No. Noopept has no FDA-approved label and is classified as an unapproved research compound. It is not authorized for any medical use in humans.
Noopept corresponds to PubChem CID 180496, with the molecular formula C17H22N2O4 and a molecular weight of 318.4. This identifies the compound structurally but does not indicate any approved or studied use.
The available data shows zero registered clinical trials for noopept. This means there is no clinical trial evidence, phase information, or outcome data to summarize for this compound.
No side effect or adverse event report data is available for this compound in the dataset reviewed. This absence of data does not confirm safety or the lack of risk.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem CID 180496
Updated 2026-08-03